1.07
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
34.45%
2.3072
|
1.716 | 1.6171 | 2.0287 | 2.2697 |
| Operating Income/Loss |
34.45%
-2.3072
|
-1.716 | -1.6171 | -2.0287 | -2.2697 |
| Net Income/Loss |
34.10%
-2.2542
|
-1.681 | -1.5783 | -1.9928 | -2.2463 |
| Basic Average Shares |
56.69%
4.2595
|
2.7184 | - | 1.6258 | 1.1903 |
| Diluted Average Shares |
56.69%
4.2595
|
2.7184 | - | 1.6258 | 1.1903 |
| Basic Earnings Per Share |
14.52%
-0.53
|
-0.62 | - | -1.23 | -1.89 |
| Diluted Earnings Per Share |
14.52%
-0.53
|
-0.62 | - | -1.23 | -1.89 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):